Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
about
Gut-brain connection: The neuroprotective effects of the anti-diabetic drug liraglutideParkinson's disease as a result of agingSerum Insulin-Like Growth Factor-1 in Patients with De Novo, Drug Naïve Parkinson's Disease: A Meta-AnalysisMeta-analyses of seven GIGYF2 polymorphisms with Parkinson's diseaseInsulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors.Recent developments in circulating biomarkers in Parkinson's disease: the potential use of miRNAs in a clinical setting.Rethinking energy in parkinsonian motor symptoms: a potential role for neural metabolic deficits.New hope for devastating neurodegenerative disease.Serum IGF-1 is associated with cognitive functions in early, drug-naïve Parkinson's disease.Potential clinical utility of multiple system atrophy biomarkers.Insulin resistance and exendin-4 treatment for multiple system atrophy.Serum microRNA expression profiling in patients with multiple system atrophy.Serum Insulin-Like Growth Factor-1 in Parkinson's Disease; Study of Cerebrospinal Fluid Biomarkers and White Matter Microstructure
P2860
Q28081671-1E67C59A-FC5C-4D32-BFD3-BE5FF5922503Q28084395-432FD70F-B808-4C1C-9211-5138302C4CB5Q28551604-863060A7-78A2-4D31-BA77-08CDF40E0BECQ34265447-66280070-E3CF-495C-97CE-769CF9B58B35Q35953962-582F5916-D91F-4CFA-B85C-E799DACC54E0Q39010887-E46D699F-BE2B-4653-98E9-BBA4451451F9Q42027560-FD831D98-F958-4A3D-BEC8-08D894175C2CQ42358593-DB9561E8-DDE9-4FE2-B049-DF1F0F8BB32FQ43690639-BFF035E4-FE6E-461D-9434-2F596A9DCFACQ47663712-9B463398-EADA-4BF3-9E1D-DDA0F8DDC155Q48249047-6D0FD343-8BD2-4D5B-8F69-B360245EC949Q49639919-E9A0C5E4-721C-4FF4-95A9-72DF934B07E8Q59137487-FDEDA723-8261-4DC7-9D76-3B029FF4AA9F
P2860
Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@en
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@nl
type
label
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@en
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@nl
prefLabel
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@en
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@nl
P2093
P1476
Clinical correlates of serum i ...... rogressive supranuclear palsy.
@en
P2093
Ayaka Numao
Keisuke Suzuki
Koichi Hirata
Masayuki Miyamoto
Tomoyuki Miyamoto
P304
P356
10.1016/J.PARKRELDIS.2013.11.005
P577
2013-11-14T00:00:00Z